Clinicopathological analysis and prognostic treatment study of angiosarcoma of the breast: a SEER population-based analysis.

Teng, Lizhi; Yan, Shuai; Du, Juntong; Yang, Ru; Xu, Peng; Tao, Weiyang

Teng, Lizhi; Yan, Shuai; Du, Juntong; Yang, Ru; Xu, Peng; Tao, Weiyang.

Affiliation

Teng L; Department of Breast Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Yan S; Key Laboratory of Acoustic, Optical and Electromagnetic Diagnosis and Treatment of Cardiovascular Diseases, Heilongjiang, China.
Du J; The Cell Transplantation Key Laboratory of National Health Commission, Harbin, Heilongjiang, 150001, China.
Yang R; Department of Breast Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Xu P; Key Laboratory of Acoustic, Optical and Electromagnetic Diagnosis and Treatment of Cardiovascular Diseases, Heilongjiang, China.
Tao W; The Cell Transplantation Key Laboratory of National Health Commission, Harbin, Heilongjiang, 150001, China.

World J Surg Oncol ; 21(1): 144, 2023 May 09.

Article de En | MEDLINE | ID: mdl-37158932

Sujet(s)
Mots clés

Angiosarcoma; Breast; SEER; Surgery; Treatment

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Hémangiosarcome Type d'étude: Prognostic_studies Limites: Female / Humans Langue: En Journal: World J Surg Oncol Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google